Cargando…
Dll1(+) quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway
Development of chemoresistance in breast cancer patients greatly increases mortality. Thus, understanding mechanisms underlying breast cancer resistance to chemotherapy is of paramount importance to overcome this clinical challenge. Although activated Notch receptors have been associated with chemor...
Autores principales: | Kumar, Sushil, Nandi, Ajeya, Singh, Snahlata, Regulapati, Rohan, Li, Ning, Tobias, John W., Siebel, Christian W., Blanco, Mario Andres, Klein-Szanto, Andres J., Lengner, Christopher, Welm, Alana L., Kang, Yibin, Chakrabarti, Rumela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813834/ https://www.ncbi.nlm.nih.gov/pubmed/33462238 http://dx.doi.org/10.1038/s41467-020-20664-5 |
Ejemplares similares
-
Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway
por: Kumar, Sushil, et al.
Publicado: (2022) -
The many facets of Notch signaling in breast cancer: toward overcoming therapeutic resistance
por: Nandi, Ajeya, et al.
Publicado: (2020) -
Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells
por: Singh, Snahlata, et al.
Publicado: (2019) -
Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer
por: Kumar, Sushil, et al.
Publicado: (2018) -
Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease
por: Ngu, Siew-Fei, et al.
Publicado: (2014)